Jared is a freelance writer for The American Journal of Managed Care® (AJMC®), and previously worked as a senior editor for HCPLive® at MJH Life Sciences®.
He has an MA from University of Sioux Falls. You can connect with Jared on LinkedIn.
Immunotherapy Changing NSCLC Care, But Many Questions Remain
A new review notes advances and remaining questions, and calls for better incorporation of data from veterans.
Read More
Nomogram Could Help Predict Early Recurrence Risk in ICC
The tool could help clinicians better screen patients for adjuvant chemotherapy following curative resection for intrahepatic cholangiocarcinoma (ICC).
SLE Recommendations Continue to Evolve as Science Advances
A new review article outlines current agreements and disagreements between association guidelines, but notes the recommendations are likely to change more in the future.
ICC Rates on the Rise Among Certain Patient Groups
Data show surgery leads to the best outcomes.
Physical Therapy Boosts Efficacy of Nusinersen in SMA, Study Shows
Patients who received regular physical therapy had improvement that was 4 times better than nusinersen alone, findings from this new study show.
COVID-19 Boosters Protective Against Infection, Severe Disease in People With SLE
A booster dose of a SARS-CoV-2 vaccine cut infection risk nearly in half, study finds.
Genetic Patterns, Targeted Therapy Resistance Link in Melanoma Explored in New Study
The analysis could help investigators better understand why a subset of patients with advanced melanoma develops resistance or does not respond to targeted therapy.
NSCLC Outcomes Improve, but Racial, Ethnic Disparities Remain
Better screenings and improved therapies have helped boost non–small cell lung cancer (NSCLC) outcomes, but investigators said some patient groups have seen less improvement than others.
High-risk Mohs Surgery Outcomes Superior to Historical Data for cSCC, Study Shows
This new report suggests patients with high-risk cutaneous squamous cell carcinoma (cSCC) have improved odds when they undergo Mohs micrographic surgery.
Treating Veterans With Advanced Lung Cancer Can Be Challenging
Veterans often have characteristics and comorbidities that can make them less likely to be included in clinical trials.
VHA Lung Cancer Screening Program Still Faces Hurdles
Over the past decade, the Veterans Health Administration (VHA) has sought to boost lung cancer screening rates, but several challenges remain.
Which Malignancies Are Most Linked With Langerhans Cell Histiocytosis?
New data show the types of malignancies, such as leukemias and myeloproliferative disorders, that are most common in children with Langerhans cell histiocytosis (LCH).
Review: Physicians Must Be Prepared for Wide Range of SLE Presentations
A narrative review shows that diagnosing systemic lupus erythematosus (SLE) requires physicians to keep an open and inquisitive mind.
Successive SLE Classification Systems May Help Clarify Mysterious Disease
Investigators note that the most recent systemic lupus erythematosus (SLE) classification system has quickly become the gold standard, but disease classification remains challenging.
Lung Cancer Treatment Efficacy Not Directly Affected by COVID-19, Study Finds
A university hospital saw an initial drop of new cases, but treatment efficacy was unaffected.
Case Report Shows Successful Liver Transplant Following HSCT in Patient With SCD
The patient was 52 years old and underwent a liver transplant 13 years after his hematopoietic stem cell transplant (HSCT) to treat his sickle cell disease (SCD).
Nomogram Developed to Predict Lupus Nephritis Outcomes in SLE
The tool relies on factors including creatinine, anti–double-stranded DNA antibody, and gender, among others.
MSI-High Status Linked With PD-1 Therapy Response in Cholangiocarcinoma
Just 5% of patients in a cholangiocarcinoma cohort were categorized as microsatellite instability high (MSI-high), but those patients tended to have “excellent” responses to therapy.
Survival Rates Have Improved, but Disparities Persist in SCLC
Patients who received a diagnosis of small cell lung cancer (SCLC) between 2010 and 2016 had a nearly 2% increase in overall survival vs those who received their diagnosis between 2004 and 2010.
Real-world Data Show Biologics Use Common, Effective in Severe Asthma
Most patients taking a biologic stayed on the therapy, and most saw decreases in exacerbations, a new study has found.
New Evidence, Mindset Could Help Better Diagnose Adult-Onset T1D
Research supports markers like C-peptide not only for the diagnosis of type 1 diabetes (T1D), but also for patient management.
Sponge Cytology “Moderately Successful” at Guiding Food Reintroduction in EoE
The data suggest the noninvasive procedure was successful in guiding food reintroduction, but missed some food triggers in certain patients.
In Hereditary TTP, Neuropsychiatric Symptoms, Stroke Are Common
A new report offers novel insights into a very small patient population.
Factors Predictive of Sustained Rituximab Response in Primary Sjögren Syndrome Identified by Study
About 43% of patients experienced complete depletion of B cells after the first round of rituximab, and those patients had greater odds of longer-term success.
CSCC Case Raises Questions About Implications of Early Response to Cemiplimab
A patient’s quick response to cemiplimab (Libtayo) was reversed after the therapy was stopped due to progression of apparent metastatic cutaneous squamous cell carcinoma.
Progress Made in Classifying iCCA, but Challenges Remain, Review Says
A dichotomous classification scheme has helped in the intrahepatic cholangiocarcinoma (iCCA) space, but some potential variants require further exploration, the article states.
Plasma IGF-1 Could Be Important Parkinson Disease Biomarker
Levels of the hormone increase with disease severity, a new study has found.
Durvalumab Timing Might Affect Pneumonitis Risk Following Chemoradiotherapy in NSCLC
The study, based on a case series in Japan, found the risk of grade 2 or above chemoradiation increased when durvalumab was started within 14 days of the final thoracic radiotherapy treatment.
Sutimlimab Shows Efficacy in Patients With CAD Without Recent Transfusion
Investigators said the benefits appeared relatively early in treatment for many patients and persisted throughout the study period.
Longitudinal Analysis Suggest Pregnancy Outcomes Unchanged in Patients With SLE
A single-center analysis of more than 30 years of data shows rates of preterm births and preeclampsia remained stable